Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.

Drozd-Sokołowska J, Zaucha JM, Żółtak T, Jamroziak K, Grzybowska-Izydorczyk O, Witkowska M, Waszczuk-Gajda A, Kaźmierczak M, Szczepaniak A, Subocz E, Knopińska-Posłuszny W, Hołojda J, Kopińska A, Hus I, Rybka J, Wołowiec D, Kwiatkowski J, Hałaburda K, Smolewski P, Giebel S, Wiktor-Jędrzejczak W.

Hematol Oncol. 2019 Apr 26. doi: 10.1002/hon.2624. [Epub ahead of print]

PMID:
31026087
2.

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).

Wiktor-Jedrzejczak W, Drozd-Sokolowska J, Eikema DJ, Hoek J, Potter M, Wulf G, Sellner L, Ljungman P, Chevallier P, Volin L, Koc Y, Martin S, Bunjes D, Rovira M, Itälä-Remes M, Foá R, Deconinck E, Gedde-Dahl T, Cornelissen J, Collin M, Brecht A, Patel A, de Groot M, Reményi P, Nagler A, Finke J, Turlure P, Iacobelli S, van Biezen A, Schetelig J, Kröger N, Dreger P.

Bone Marrow Transplant. 2019 Sep;54(9):1391-1398. doi: 10.1038/s41409-019-0448-x. Epub 2019 Jan 21.

PMID:
30664723
3.

The Emerging Link Between the Complement Cascade and Purinergic Signaling in Stress Hematopoiesis.

Ratajczak MZ, Adamiak M, Kucia M, Tse W, Ratajczak J, Wiktor-Jedrzejczak W.

Front Immunol. 2018 Jun 5;9:1295. doi: 10.3389/fimmu.2018.01295. eCollection 2018. Review.

4.

Autologous peripheral blood stem cell transplantation in dialysis-dependent multiple myeloma patients-DAUTOS Study of the Polish Myeloma Study Group.

Waszczuk-Gajda A, Lewandowski Z, Drozd-Sokołowska J, Boguradzki P, Dybko J, Wróbel T, Basak GW, Jurczyszyn A, Mądry K, Snarski E, Frączak E, Charliński G, Feliksbrot-Bratosiewicz M, Król M, Matuszkiewicz-Rowińska J, Klinger M, Krajewska M, Augustyniak-Bartosik H, Kościelska M, Rusicka P, Dwilewicz-Trojaczek J, Wiktor Jędrzejczak W.

Eur J Haematol. 2018 Oct;101(4):475-485. doi: 10.1111/ejh.13101. Epub 2018 Jul 4.

PMID:
29797662
5.

Continuous Mononuclear Cell Collection (cMNC) protocol impact on hematopoietic stem cell collections in donors with negative collection predictors.

Bartnik K, Maciejewska M, Farhan R, Urbanowska E, Król M, Król M, Feliksbrot M, Wiktor-Jędrzejczak W, Snarski E.

Transfus Apher Sci. 2018 Jun;57(3):401-405. doi: 10.1016/j.transci.2018.04.022. Epub 2018 Apr 22.

PMID:
29778714
6.

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.

Kantarjian HM, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Carpenter N, Mehta B, Franklin J, Giagounidis A.

Lancet Haematol. 2018 Mar;5(3):e117-e126. doi: 10.1016/S2352-3026(18)30016-4. Epub 2018 Jan 26.

PMID:
29396092
7.

Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.

Sahebi F, Iacobelli S, Sbianchi G, Koster L, Blaise D, Reményi P, Russell NH, Ljungman P, Kobbe G, Apperley J, Trneny M, Krejci M, Wiktor-Jedrzejczak W, Sanchez JF, Schaap N, Isaksson C, Lenhoff S, Browne P, Scheid C, Wilson KMO, Yakoub-Agha I, Muñiz SG, Schönland S, Morris C, Garderet L, Kröger N.

Biol Blood Marrow Transplant. 2018 May;24(5):930-936. doi: 10.1016/j.bbmt.2018.01.006. Epub 2018 Jan 12.

8.

Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.

Auner HW, Iacobelli S, Sbianchi G, Knol-Bout C, Blaise D, Russell NH, Apperley JF, Pohlreich D, Browne PV, Kobbe G, Isaksson C, Lenhoff S, Scheid C, Touzeau C, Jantunen E, Anagnostopoulos A, Yakoub-Agha I, Tanase A, Schaap N, Wiktor-Jedrzejczak W, Krejci M, Schönland SO, Morris C, Garderet L, Kröger N.

Haematologica. 2018 Mar;103(3):514-521. doi: 10.3324/haematol.2017.181339. Epub 2017 Dec 7.

9.

Nutritional Status of Hematological Patients before Hematopoietic Stem Cell Transplantation and in Early Posttransplantation Period.

Krawczyk J, Kraj L, Korta T, Wiktor-Jędrzejczak W.

Nutr Cancer. 2017 Nov-Dec;69(8):1205-1210. doi: 10.1080/01635581.2017.1367937. Epub 2017 Sep 22.

PMID:
28937794
10.

Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.

Farhan R, Urbanowska E, Zborowska H, Król M, Król M, Torosian T, Piotrowska I, Bogusz K, Skwierawska K, Wiktor-Jędrzejczak W, Snarski E.

Ann Hematol. 2017 Oct;96(10):1735-1739. doi: 10.1007/s00277-017-3060-4. Epub 2017 Aug 11.

11.

Bone marrow harvest from unrelated donors-up-to-date methodology.

Pruszczyk K, Skwierawska K, Król M, Moskowicz A, Jabłoński D, Torosian T, Piotrowska I, Urbanowska E, Wiktor-Jędrzejczak W, Snarski E.

Eur J Haematol. 2017 Oct;99(4):357-365. doi: 10.1111/ejh.12929.

PMID:
28719093
12.

Similar but not the same: Differential diagnosis of HLH and sepsis.

Machowicz R, Janka G, Wiktor-Jedrzejczak W.

Crit Rev Oncol Hematol. 2017 Jun;114:1-12. doi: 10.1016/j.critrevonc.2017.03.023. Epub 2017 Mar 23. Review.

PMID:
28477737
13.

Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study.

Bilinski J, Grzesiowski P, Sorensen N, Madry K, Muszynski J, Robak K, Wroblewska M, Dzieciatkowski T, Dulny G, Dwilewicz-Trojaczek J, Wiktor-Jedrzejczak W, Basak GW.

Clin Infect Dis. 2017 Aug 1;65(3):364-370. doi: 10.1093/cid/cix252.

PMID:
28369341
14.

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.

Hochhaus A, Masszi T, Giles FJ, Radich JP, Ross DM, Gómez Casares MT, Hellmann A, Stentoft J, Conneally E, García-Gutiérrez V, Gattermann N, Wiktor-Jedrzejczak W, le Coutre PD, Martino B, Saussele S, Menssen HD, Deng W, Krunic N, Bedoucha V, Saglio G.

Leukemia. 2017 Jul;31(7):1525-1531. doi: 10.1038/leu.2017.63. Epub 2017 Feb 20.

15.

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Pluta A, Robak T, Wrzesien-Kus A, Katarzyna Budziszewska B, Sulek K, Wawrzyniak E, Czemerska M, Zwolinska M, Golos A, Holowiecka-Goral A, Kyrcz-Krzemien S, Piszcz J, Kloczko J, Mordak-Domagala M, Lange A, Razny M, Madry K, Wiktor-Jedrzejczak W, Grosicki S, Butrym A, Kuliczkowski K, Warzocha K, Holowiecki J, Giebel S, Szydlo R, Wierzbowska A.

Am J Hematol. 2017 Apr;92(4):359-366. doi: 10.1002/ajh.24654. Epub 2017 Feb 13.

16.

Prognostic factors in the survival of patients with blood disorders recovering from septic shock.

Waszczuk-Gajda A, Wiktor Jedrzejczak W.

Hematology. 2017 Jun;22(5):292-298. doi: 10.1080/10245332.2016.1253521. Epub 2016 Nov 17.

PMID:
27854183
17.

Are myelodysplastic syndromes underdiagnosed in Poland? A report by the Polish Adult Leukaemia Group.

Drozd-Sokołowska JE, Mądry K, Waszczuk-Gajda A, Żółtak T, Sikorska A, Mital A, Wajs J, Semeńczuk G, Szmigielska-Kapłon A, Szczepańska M, Wasilewska E, Szwedyk P, Hołojda J, Wątek M, Stella-Hołowiecka B, Soroka-Wojtaszko M, Homenda W, Polak M, Guzicka-Kazimierska R, Porowska A, Wiktor-Jędrzejczak W, Dwilewicz-Trojaczek J.

Eur J Haematol. 2017 Feb;98(2):154-159. doi: 10.1111/ejh.12814. Epub 2016 Nov 1.

PMID:
27699872
18.

Rhinosinusitis in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation-A Single-Center Experience.

Drozd-Sokołowska J, Sokołowski J, Biecek P, Niemczyk K, Basak GW, Wiktor-Jędrzejczak W.

Transplant Proc. 2016 Jun;48(5):1797-801. doi: 10.1016/j.transproceed.2016.03.013.

PMID:
27496494
19.

Activation of the complement cascade enhances motility of leukemic cells by downregulating expression of HO-1.

Abdelbaset-Ismail A, Borkowska-Rzeszotek S, Kubis E, Bujko K, Brzeźniakiewicz-Janus K, Bolkun L, Kloczko J, Moniuszko M, Basak GW, Wiktor-Jedrzejczak W, Ratajczak MZ.

Leukemia. 2017 Feb;31(2):446-458. doi: 10.1038/leu.2016.198. Epub 2016 Jul 25.

20.

Your critical care patient may have HLH (hemophagocytic lymphohistiocytosis).

Machowicz R, Janka G, Wiktor-Jedrzejczak W.

Crit Care. 2016 Jul 6;20(1):215. doi: 10.1186/s13054-016-1369-3. No abstract available.

21.

A Preliminary Online Study on Menstruation Recovery in Women After Autologous Hematopoietic Stem Cell Transplant for Autoimmune Diseases.

Maciejewska M, Snarski E, Wiktor-Jędrzejczak W.

Exp Clin Transplant. 2016 Dec;14(6):665-669. doi: 10.6002/ect.2015.0336. Epub 2016 Jun 15.

22.

Sinusitis in patients undergoing allogeneic bone marrow transplantation - a review.

Drozd-Sokolowska JE, Sokolowski J, Wiktor-Jedrzejczak W, Niemczyk K.

Braz J Otorhinolaryngol. 2017 Jan - Feb;83(1):105-111. doi: 10.1016/j.bjorl.2016.02.012. Epub 2016 Apr 22. Review.

23.

Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host.

Biliński J, Grzesiowski P, Muszyński J, Wróblewska M, Mądry K, Robak K, Dzieciątkowski T, Wiktor-Jedrzejczak W, Basak GW.

Arch Immunol Ther Exp (Warsz). 2016 Jun;64(3):255-8. doi: 10.1007/s00005-016-0387-9. Epub 2016 Mar 9.

24.

Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study.

Bilinski J, Robak K, Peric Z, Marchel H, Karakulska-Prystupiuk E, Halaburda K, Rusicka P, Swoboda-Kopec E, Wroblewska M, Wiktor-Jedrzejczak W, Basak GW.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1087-1093. doi: 10.1016/j.bbmt.2016.02.009. Epub 2016 Feb 18.

25.

Immunoablation and autologous hematopoietic stem cell transplantation in the treatment of new-onset type 1 diabetes mellitus: long-term observations.

Snarski E, Milczarczyk A, Hałaburda K, Torosian T, Paluszewska M, Urbanowska E, Król M, Boguradzki P, Jedynasty K, Franek E, Wiktor-Jedrzejczak W.

Bone Marrow Transplant. 2016 Mar;51(3):398-402. doi: 10.1038/bmt.2015.294. Epub 2015 Dec 7.

PMID:
26642342
26.

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

Hochhaus A, Rosti G, Cross NC, Steegmann JL, le Coutre P, Ossenkoppele G, Petrov L, Masszi T, Hellmann A, Griskevicius L, Wiktor-Jedrzejczak W, Rea D, Coriu D, Brümmendorf TH, Porkka K, Saglio G, Gastl G, Müller MC, Schuld P, Di Matteo P, Pellegrino A, Dezzani L, Mahon FX, Baccarani M, Giles FJ.

Leukemia. 2016 Jan;30(1):57-64. doi: 10.1038/leu.2015.270. Epub 2015 Oct 6.

27.

Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias.

Kohgo Y, Urabe A, Kilinç Y, Agaoglu L, Warzocha K, Miyamura K, Lim LC, Glaser S, Wang C, Wiktor-Jedrzejczak W.

Acta Haematol. 2015;134(4):233-42.

28.

An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes.

Snarski E, Szmurło D, Hałaburda K, Król M, Urbanowska E, Milczarczyk A, Franek E, Wiktor-Jedrzejczak W.

Acta Diabetol. 2015 Oct;52(5):881-8. doi: 10.1007/s00592-015-0724-1. Epub 2015 Mar 6.

PMID:
25744552
29.

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT.

Basak GW, Wiktor-Jedrzejczak W, Labopin M, Schoemans H, Ljungman P, Kobbe G, Beguin Y, Lang P, Koenecke C, Sykora KW, Te Boome L, van Biezen A, van der Werf S, Mohty M, de Witte T, Marsh J, Dreger P, Kröger N, Duarte R, Ruutu T.

Am J Transplant. 2015 Mar;15(3):705-14. doi: 10.1111/ajt.13017. Epub 2015 Feb 3.

30.

Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study.

Budziszewska BK, Pluta A, Sulek K, Wierzbowska A, Robak T, Giebel S, Holowiecka-Goral A, Sawicki W, Ejduk A, Patkowska E, Manko J, Gajkowska-Kulik J, Piszcz J, Mordak-Domagala M, Madry K, Holowiecki J, Kyrcz-Krzemien S, Nowakowska-Domagala M, Dmoszynska A, Calbecka M, Kloczko J, Wiktor Jędrzejczak W, Lange A, Razny M, Bilinski P, Warzocha K, Lech-Maranda E.

Leuk Lymphoma. 2015;56(8):2331-8. doi: 10.3109/10428194.2014.985672. Epub 2015 Jan 21.

PMID:
25393675
31.

High-dose melphalan and autologous hematopoietic stem cell transplantation in primary amyloidosis: single-center results.

Charlinski G, Ziarkiewicz M, Boguradzki P, Wiater E, Torosian T, Dwilewicz-Trojaczek J, Wiktor-Jedrzejczak W.

Transplant Proc. 2014 Oct;46(8):2877-81. doi: 10.1016/j.transproceed.2014.09.053.

PMID:
25380940
32.

Metabolic and nutritional aspects of cancer.

Krawczyk J, Kraj L, Ziarkiewicz M, Wiktor-Jędrzejczak W.

Postepy Hig Med Dosw (Online). 2014 Aug 22;68:1008-14. doi: 10.5604/17322693.1118194. Review.

33.

[Light chain amyloidosis--clinical symptoms, update diagnosis, and treatment].

Charliński G, Jurczyszyn A, Wiktor-Jedrzejczak W.

Przegl Lek. 2014;71(2):102-9. Review. Polish.

PMID:
25016786
34.

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia.

Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Hu K, Woodard P, Yang AS, Kantarjian HM.

Cancer. 2014 Jun 15;120(12):1838-46. doi: 10.1002/cncr.28663. Epub 2014 Apr 4.

35.

An isolated outbreak of influenza A H1N1 in a haematological department during post-pandemic period.

Drozd-Sokołowska JE, Dulny G, Waszczuk-Gajda A, Wiktor-Jędrzejczak W.

Przegl Epidemiol. 2014;68(4):621-6. English, Polish.

36.

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, Dazzi F, Dreger P, Duarte R, Finke J, Garderet L, Greinix H, Holler E, Kröger N, Lawitschka A, Mohty M, Nagler A, Passweg J, Ringdén O, Socié G, Sierra J, Sureda A, Wiktor-Jedrzejczak W, Madrigal A, Niederwieser D.

Bone Marrow Transplant. 2014 Feb;49(2):168-73. doi: 10.1038/bmt.2013.107. Epub 2013 Jul 29. Erratum in: Bone Marrow Transplant. 2014 Feb;49(2):319. Dosage error in article text.

PMID:
23892326
37.

Intrapericardial and intrapleural administration of rituximab to a patient with marginal zone lymphoma.

Boguradzki P, Drozd-Sokolowska JE, Wieczorek J, Kowalik R, Starczewska M, Krol M, Kobylecka M, Opolski G, Wiktor-Jedrzejczak W.

Acta Haematol. 2013;130(3):169-71. doi: 10.1159/000348414. Epub 2013 May 28.

PMID:
23735747
38.

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation.

Basak GW, de Wreede LC, van Biezen A, Wiktor-Jedrzejczak W, Halaburda K, Schmid C, Schaap N, Dazzi F, von dem Borne PA, Petersen E, Beelen D, Abayomi A, Volin L, Buzyn A, Gurman G, Bunjes D, Guglielmi C, Olavarria E, de Witte T.

Bone Marrow Transplant. 2013 Jun;48(6):837-42. doi: 10.1038/bmt.2012.234. Epub 2012 Nov 26.

PMID:
23178548
39.

Continuous lenalidomide treatment for newly diagnosed multiple myeloma.

Palumbo A, Hajek R, Delforge M, Kropff M, Petrucci MT, Catalano J, Gisslinger H, Wiktor-Jędrzejczak W, Zodelava M, Weisel K, Cascavilla N, Iosava G, Cavo M, Kloczko J, Bladé J, Beksac M, Spicka I, Plesner T, Radke J, Langer C, Ben Yehuda D, Corso A, Herbein L, Yu Z, Mei J, Jacques C, Dimopoulos MA; MM-015 Investigators.

N Engl J Med. 2012 May 10;366(19):1759-69. doi: 10.1056/NEJMoa1112704. Erratum in: N Engl J Med. 2012 Jul 19;367(3):285.

40.

Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.

Nieborowska-Skorska M, Kopinski PK, Ray R, Hoser G, Ngaba D, Flis S, Cramer K, Reddy MM, Koptyra M, Penserga T, Glodkowska-Mrowka E, Bolton E, Holyoake TL, Eaves CJ, Cerny-Reiterer S, Valent P, Hochhaus A, Hughes TP, van der Kuip H, Sattler M, Wiktor-Jedrzejczak W, Richardson C, Dorrance A, Stoklosa T, Williams DA, Skorski T.

Blood. 2012 May 3;119(18):4253-63. doi: 10.1182/blood-2011-10-385658. Epub 2012 Mar 12.

41.

Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium.

Wiktor-Jedrzejczak W, Dearden C, de Wreede L, van Biezen A, Brinch L, Leblond V, Brune M, Volin L, Kazmi M, Nagler A, Schetelig J, de Witte T, Dreger P; EBMT Chronic Leukemia Working Party.

Leukemia. 2012 May;26(5):972-6. doi: 10.1038/leu.2011.304. Epub 2011 Nov 25.

PMID:
22116553
42.

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.

Basak GW, Wiktor-Jedrzejczak W, Apperley JF, Douglas KW, Gabriel IH, Geraldes C, Hübel K, Jaksic O, Koristek Z, Lanza F, Lemoli R, Mikala G, Selleslag D, Worel N, Mohty M, Duarte RF.

Bone Marrow Transplant. 2012 Jul;47(7):1003-5. doi: 10.1038/bmt.2011.199. Epub 2011 Oct 10. No abstract available.

PMID:
21986638
43.

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.

Basak GW, Jaksic O, Koristek Z, Mikala G, Mayer J, Masszi T, Labar B, Wiktor-Jedrzejczak W; Central and Eastern European Leukemia Group (CELG).

Am J Hematol. 2011 Jul;86(7):550-3. doi: 10.1002/ajh.22038. Epub 2011 Jun 14.

44.

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.

Basak GW, Mikala G, Koristek Z, Jaksic O, Basic-Kinda S, Cegledi A, Reti M, Masszi T, Mayer J, Giebel S, Hübel K, Labar B, Wiktor-Jedrzejczak W.

Leuk Lymphoma. 2011 Sep;52(9):1711-9. doi: 10.3109/10428194.2011.578312. Epub 2011 Jun 12.

PMID:
21663509
45.

Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells.

Basak GW, Jaksic O, Koristek Z, Mikala G, Basic-Kinda S, Mayer J, Masszi T, Giebel S, Labar B, Wiktor-Jedrzejczak W; Central and Eastern European Leukaemia Group (CELG).

Eur J Haematol. 2011 Jun;86(6):488-95. doi: 10.1111/j.1600-0609.2011.01605.x. Epub 2011 Apr 1.

PMID:
21410533
46.

Factors determining the risk of severe (WHO grades 3 and 4) hemorrhage in hematologic patients.

Drozd-Sokolowska JE, Wiktor-Jedrzejczak W.

Transfus Apher Sci. 2011 Apr;44(2):129-34. doi: 10.1016/j.transci.2011.01.004. Epub 2011 Feb 18.

PMID:
21334260
47.

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.

Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Wiktor-Jedrzejczak W, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD.

Blood. 2011 Mar 24;117(12):3294-301. doi: 10.1182/blood-2010-08-301796. Epub 2011 Jan 26.

48.

Booster of plerixafor can be successfully used in addition to chemotherapy-based regimen to rescue stem cell mobilization failure.

Basak GW, Urbanowska E, Boguradzki P, Torosian T, Halaburda K, Wiktor-Jedrzejczak W.

Ann Transplant. 2010 Oct-Dec;15(4):61-7.

PMID:
21183878
49.

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience.

Basak GW, Knopinska-Posluszny W, Matuszak M, Kisiel E, Hawrylecka D, Szmigielska-Kaplon A, Urbaniak-Kujda D, Dybko J, Zielinska P, Dabrowska-Iwanicka A, Werkun J, Rzepecki P, Wroblewska W, Wiktor-Jedrzejczak W.

Ann Hematol. 2011 May;90(5):557-68. doi: 10.1007/s00277-010-1098-7. Epub 2010 Oct 12.

50.

Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland.

Basak GW, Drozd-Sokołowska J, Wiktor-Jedrzejczak W.

J Int Med Res. 2010 Jul-Aug;38(4):1374-80.

PMID:
20926010

Supplemental Content

Loading ...
Support Center